Skip to content
Screener

Lifecore Biomedical, Inc. LFCR Q3 2026 earnings

Reported March 16, 2026 · Before market open

Revenue$35.2MBeat by $2.0M
EPS-$0.16Beat by $0.11
Revenue estimate$33.1M
EPS estimate-$0.27

Next report

Date not yet announced

Financials

Q3 2026

Balance sheet

See full
Cash & equivalents$17.5M+223%
Total debt$143.2M+4.3%
Total equity-$14.2M-739%
Total assets$232.2M-2.3%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$269.76M+24.8%
Enterprise value$395.48M+13.6%

Returns & leverage

See full
Current ratio3.5×+0.8×

FAQ

When did Lifecore Biomedical, Inc. report Q3 2026 earnings?
Lifecore Biomedical, Inc. (LFCR) reported Q3 2026 earnings on March 16, 2026 before market open.
What were Lifecore Biomedical, Inc.'s Q3 2026 revenue and EPS?
Lifecore Biomedical, Inc. reported revenue of $35.2M and eps of $-0.16 for Q3 2026.
Did Lifecore Biomedical, Inc. beat estimates in Q3 2026?
Revenue beat the consensus estimate of $33.1M by $2.0M. EPS beat the consensus estimate of $-0.27 by $0.11.
Where can I find Lifecore Biomedical, Inc.'s Q3 2026 SEC filings?
You can read the 8-K earnings release (0001005286-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.